Published by
@ShahidNShah
@ShahidNShah
0-50Biotechnology Research
, San Francisco, California, United States
Mana.bio, an AI-powered drug delivery startup, spearheads Lipid Nanoparticle (LNP) development. Their focus lies in oligonucleotide therapies, encompassing mRNA-based treatments, vaccines, and gene therapy. Leveraging AI, they craft a robust platform to enhance LNP formulation for efficient drug delivery. This innovative approach revolutionizes how oligonucleotide therapies are developed and administered, promising groundbreaking advancements in mRNA-based therapeutics and gene therapy.
IMana.bio, an AI-based drug delivery startup, revolutionizes gene therapy, RNADNA therapeutics, and vaccines.Merging machine learning and nanotechnology, they pioneer genetic medicine. Their AI-driven …
Posted Artificial Intelligence Pharmaceuticals, Biotechnology & Drug Discovery Technologies
Last Updated
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on May 13, 2024 at 3:24pm